sz.kidsadvices.com
Comments

The first uterine cancer vaccine is marketed in the US

The first uterine cancer vaccine is marketed in the US


We are searching data for your request:

Forums and discussions:
Manuals and reference books:
Data from registers:
Wait the end of the search in all databases.
Upon completion, a link will appear to access the found materials.


The world's first uterine cancer vaccine, obtained by US pharmaceutical laboratories Merck, received the Green Wave from the Food and Drug Administration (FDA) for commercialization on Thursday, reports AFP consulted by Rompres.

The world's first uterine cancer vaccine, obtained by US pharmaceutical laboratories Merck, received the Green Wave from the Food and Drug Administration (FDA) for commercialization on Thursday, reports AFP consulted by Rompres.
This vaccine called Gardasil is intended for young girls between the ages of 9 and 26 years old and has the role of protecting them against HPV virus infections responsible for uterine lesions that can develop into cancer, the FDA release said.
This type of infection is responsible for over 70% of all cervical cancers.
Gardasil protects the body against four variants of the HPV virus, of which two versions, HPV 16 and HPV 18 are directly responsible for uterine cancer, and the other two, HPV 6 and HPV 11, are the cause of serious anal-genital disorders and cancer. vagina.


Worldwide cervical cancer is the second most common occurrence in women, with approximately 470,000 new cases each year and an annual mortality rate of over 233,000 cases, of which over 80% in developing countries.
But even the developed countries are not protected. In the US alone, over 9,700 new cases of uterine cancer are registered annually and over 3,700 deaths caused by this disease in the same unit of time.
The high incidence of this type of cancer is caused by the fact that the transmission of the HPV virus can be done sexually. Under these conditions, about 6.2 million Americans become infected with the HPV virus each year, and more than half of adults (men and women) who are sexually active in the United States are infected at one point in their life with the HPV virus.
"This vaccine is an important leap forward in protecting women's health, giving them immunity from infections responsible for the occurrence of a large number of uterine cancers," the FDA release said.
The four clinical trials conducted by Merck laboratories on 21,000 women volunteers in the United States and several other countries have shown that this new vaccine has nearly 100% efficacy against the four types of HPV viruses responsible for the precancerous lesions of HPV. cervix, but also of the vulva.
Rompres
June 9, 2006


Comments:

  1. Meccus

    Funny topic

  2. Bodwyn

    I think this is a great idea. Fully agree with her.

  3. Lawford

    Bravo, the brilliant idea and it is timely

  4. Garvan

    I am final, I am sorry, but it not absolutely approaches me. Perhaps there are still variants?

  5. Gaagii

    Now everything has become clear, many thanks for the explanation.

  6. Taye

    I thank for the information.



Write a message